Treace Medical Concepts, Inc. Earnings Per Share (Diluted)
Treace Medical Concepts, Inc. (TMCI) reported Earnings Per Share (Diluted) of -$0.24 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareDiluted · last filed 2026-08-07
- Treace Medical Concepts, Inc. earnings per share, diluted for the quarter ending 2026-06-30 was -$0.24.
- Treace Medical Concepts, Inc. earnings per share, diluted for the quarter ending 2026-03-31 was -$0.28.
- Treace Medical Concepts, Inc. earnings per share, diluted for the quarter ending 2025-12-31 was -$0.15.
- Treace Medical Concepts, Inc. earnings per share, diluted for the quarter ending 2025-09-30 was -$0.26.
- Treace Medical Concepts, Inc. earnings per share, diluted for fiscal 2025 was -$0.93.
- Treace Medical Concepts, Inc. earnings per share, diluted for fiscal 2024 was -$0.90.
- Treace Medical Concepts, Inc. earnings per share, diluted for fiscal 2023 was -$0.81.
- Treace Medical Concepts, Inc. earnings per share, diluted for fiscal 2022 was -$0.77.
| Period end | Earnings Per Share, Diluted 3 month | Earnings Per Share, Diluted 6 month | Earnings Per Share, Diluted 9 month | Earnings Per Share, Diluted 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$0.24 10-Q · filed 2026-08-07 | -$0.52 10-Q · filed 2026-08-07 | -$0.67 derived: net income ÷ weighted average shares · filed 2026-08-07 | -$0.93 derived: net income ÷ weighted average shares · filed 2026-08-07 |
| 2026-03-31 | -$0.28 10-Q · filed 2026-05-08 | -$0.43 derived: net income ÷ weighted average shares · filed 2026-08-07 | -$0.68 derived: net income ÷ weighted average shares · filed 2026-08-07 | -$0.96 derived: net income ÷ weighted average shares · filed 2026-08-07 |
| 2025-12-31 | -$0.15 derived: net income ÷ weighted average shares · filed 2026-04-06 | -$0.40 derived: net income ÷ weighted average shares · filed 2026-04-06 | -$0.68 derived: net income ÷ weighted average shares · filed 2026-08-07 | -$0.93 10-K · filed 2026-02-27 |
| 2025-09-30 | -$0.26 10-Q · filed 2025-11-06 | -$0.53 derived: net income ÷ weighted average shares · filed 2026-08-07 | -$0.79 10-Q · filed 2025-11-06 | -$0.80 derived: net income ÷ weighted average shares · filed 2026-08-07 |
| 2025-06-30 | -$0.28 10-Q · filed 2026-08-07 | -$0.53 10-Q · filed 2026-08-07 | -$0.54 derived: net income ÷ weighted average shares · filed 2026-08-07 | -$0.79 derived: net income ÷ weighted average shares · filed 2026-08-07 |
| 2025-03-31 | -$0.25 10-Q · filed 2026-05-08 | -$0.26 derived: net income ÷ weighted average shares · filed 2026-08-07 | -$0.51 derived: net income ÷ weighted average shares · filed 2026-08-07 | -$0.85 derived: net income ÷ weighted average shares · filed 2026-08-07 |
| 2024-12-31 | -$0.01 derived: net income ÷ weighted average shares · filed 2026-04-06 | -$0.25 derived: net income ÷ weighted average shares · filed 2026-04-06 | -$0.60 derived: net income ÷ weighted average shares · filed 2026-04-06 | -$0.90 10-K · filed 2026-02-27 |
| 2024-09-30 | -$0.25 10-Q · filed 2025-11-06 | -$0.59 derived: net income ÷ weighted average shares · filed 2025-11-06 | -$0.89 10-Q · filed 2025-11-06 | -$1.00 derived: net income ÷ weighted average shares · filed 2026-04-06 |
| 2024-06-30 | -$0.34 10-Q · filed 2025-08-07 | -$0.64 10-Q · filed 2025-08-07 | -$0.75 derived: net income ÷ weighted average shares · filed 2026-04-06 | -$1.04 derived: net income ÷ weighted average shares · filed 2026-04-06 |
| 2024-03-31 | -$0.30 10-Q · filed 2025-05-08 | -$0.41 derived: net income ÷ weighted average shares · filed 2026-04-06 | -$0.70 derived: net income ÷ weighted average shares · filed 2026-04-06 | -$0.90 derived: net income ÷ weighted average shares · filed 2026-04-06 |
| 2023-12-31 | -$0.11 derived: net income ÷ weighted average shares · filed 2026-04-06 | -$0.39 derived: net income ÷ weighted average shares · filed 2026-04-06 | -$0.59 derived: net income ÷ weighted average shares · filed 2026-04-06 | -$0.81 10-K · filed 2026-02-27 |
| 2023-09-30 | -$0.28 10-Q · filed 2024-11-05 | -$0.48 derived: net income ÷ weighted average shares · filed 2024-11-05 | -$0.71 10-Q · filed 2024-11-05 | -$0.81 derived: net income ÷ weighted average shares · filed 2026-04-06 |
| 2023-06-30 | -$0.20 10-Q · filed 2024-08-06 | -$0.43 10-Q · filed 2024-08-06 | -$0.52 derived: net income ÷ weighted average shares · filed 2026-04-06 | -$0.73 derived: net income ÷ weighted average shares · filed 2026-04-06 |
| 2023-03-31 | -$0.23 10-Q · filed 2024-05-07 | -$0.32 derived: net income ÷ weighted average shares · filed 2026-04-06 | -$0.53 derived: net income ÷ weighted average shares · filed 2026-04-06 | -$0.84 derived: net income ÷ weighted average shares · filed 2026-04-06 |
| 2022-12-31 | -$0.08 derived: net income ÷ weighted average shares · filed 2026-04-06 | -$0.30 derived: net income ÷ weighted average shares · filed 2026-04-06 | -$0.61 derived: net income ÷ weighted average shares · filed 2026-04-06 | -$0.77 10-K · filed 2025-02-27 |
| 2022-09-30 | -$0.22 10-Q · filed 2023-11-09 | -$0.53 derived: net income ÷ weighted average shares · filed 2023-11-09 | -$0.70 10-Q · filed 2023-11-09 | -$0.82 derived: net income ÷ weighted average shares · filed 2024-02-27 |
| 2022-06-30 | -$0.31 10-Q · filed 2023-08-09 | -$0.48 10-Q · filed 2023-08-09 | -$0.60 derived: net income ÷ weighted average shares · filed 2024-02-27 | -$0.73 derived: net income ÷ weighted average shares · filed 2024-02-27 |
| 2022-03-31 | -$0.16 10-Q · filed 2023-05-09 | -$0.29 derived: net income ÷ weighted average shares · filed 2024-02-27 | -$0.41 derived: net income ÷ weighted average shares · filed 2024-02-27 | -$0.52 derived: net income ÷ weighted average shares · filed 2024-02-27 |
| 2021-12-31 | -$0.12 derived: net income ÷ weighted average shares · filed 2024-02-27 | -$0.24 derived: net income ÷ weighted average shares · filed 2024-02-27 | -$0.35 derived: net income ÷ weighted average shares · filed 2024-02-27 | -$0.43 10-K · filed 2024-02-27 |
| 2021-09-30 | -$0.12 10-Q · filed 2022-11-09 | -$0.23 derived: net income ÷ weighted average shares · filed 2022-11-09 | -$0.30 10-Q · filed 2022-11-09 | |
| 2021-06-30 | -$0.10 10-Q · filed 2022-08-10 | -$0.18 10-Q · filed 2022-08-10 | ||
| 2020-12-31 | -$0.12 10-K · filed 2023-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |